Skip to content

Construction and Preliminary Evaluation of a Stratified Intervention Program for Demoralization Syndrome in Lung Cancer Patients Based on Digital Narrative

Construction and Preliminary Evaluation of a Stratified Intervention Program for Demoralization Syndrome in Lung Cancer Patients Based on Digital Narrative

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600122000
Enrollment
Unknown
Registered
2026-04-08
Start date
2026-04-20
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Lung Cancer

Interventions

Control group:Routine care
Intervention Group:Stratified Intervention for Demoralization Syndrome in Lung Cancer Patients Based on Digital Narrative

Sponsors

Fujian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Pathologically confirmed diagnosis of primary lung cancer; 2.First-time use of combined therapy (chemotherapy + other therapies), and expected to receive at least 4 cycles of chemotherapy; 3.Age >= 18 years old; 4.Karnofsky Performance Status score >= 60; 5.Being aware of the diagnosis and voluntarily participating in the study; 6.Conscious and clear-minded, with adequate reading comprehension and verbal expression skills; 7.Lung cancer patients with low or moderate demoralization, whose subgroup assignment was identified using latent class analysis (LCA); 8.Possess basic digital device operation skills (operating a smartphone).

Exclusion criteria

Exclusion criteria: 1.Patients with mental illness or currently receiving mental health treatment; 2.Presence of cognitive impairment (Chinese version of the MoCA score <= 25), personality disorders, intellectual disability, brain injury, or brain disorders; 3.Patients with malignant tumors at other sites; 4.Patients with concurrent severe complications, such as malignant pleural effusion, bronchopleural fistula, and others; 5.Patients with an expected survival of <1 year (per attending physician judgment); 6.Patients who have experienced significant life events within the past 3 months (e.g., death of an immediate family member, major accidental injury).

Design outcomes

Primary

MeasureTime frame
Demoralization;

Secondary

MeasureTime frame
Resilience;Symptom Burden;Feasibility;Security;Coping;

Countries

China

Contacts

Public ContactHuang Feifei

Fujian Medical University

pt860315@163.com+86 591 22865051

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026